Company profile
Qscreen Ai Inc.
OTC: PMEDF · Healthcare · Medical - Devices
Canadian filerHQ Toronto, ONCIK 0001868079Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 25
v0.1 · 5/100 weight · pillars only
↑ market scale, balance-sheet leverage · ↓ filing timeliness, workforce scale
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.6M
Employees
3
as of 2026-08-22
Market cap
$4.8M
as of 2026-08-22
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$1.6M-2.1M CAD2023
Total assets$537.6k717.7k CAD2023
Liabilities$652.5k871.1k CAD2023
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Qscreen Ai Inc.’s financial profile?
Qscreen Ai Inc. earned -$1.6M in FY2023 net income.
Peers · Healthcare
Cadrenal Therapeutics, Inc. Common Stock——CordovaCann Corp.——Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst——Xcelerate Inc.——LianBio——Revelation Biosciences, Inc.——Key facts
CEOSheldon Kales
SectorHealthcare
IndustryMedical - Devices
HeadquartersToronto, ON
ExchangeOTC: PMEDF
Employees3
IPO date2021-01-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.